29 June 2026
EUROCELL PLC
(the "Company")
Director/PDMR Shareholding
Eurocell plc announces that, pursuant to the Non-executive Directors' Share Purchase Plan which was announced today, four directors have purchased shares in the Company on 26 June 2026.
Following these purchases, the total reportable shareholding in the Company for each Non-executive Director (including those held by their respective PCAs) is:
- Derek Mapp holds 680,225 Ordinary Shares. This equates to 0.69% of the voting rights of the Company.
- Alison Littley holds 22,789 Ordinary Shares. This equates to 0.02% of the voting rights of the Company.
- Iraj Amiri holds 75,876 Ordinary Shares. This equates to 0.08% of the voting rights of the Company.
- Angela Rushforth holds 12,051 Ordinary Shares. This equates to 0.01% of the voting rights of the Company.
The notification set out below, made in accordance with the requirements of the UK Market Abuse Regulation, provides further details.
Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them.
1. Details of PDMR / person closely associated with them ("PCA") | a) Name Derek Mapp | 2. Reason for the notification | a) Position / status Non-executive Director (Chair of the Board) | b) Initial notification / amendment Initial Notification | 3. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | a) Name Eurocell plc | b) Legal Entity Identifier 213800RH62IQ7S9OFQ55 | 4. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | a) Description of the financial instrument Ordinary shares of £0.001 each in the Company ("Ordinary Shares") ISIN Number GB00BVV2KN49 | b) Nature of the transaction Purchase of Ordinary shares pursuant to the Non-executive Directors' Share Purchase Plan | c) Price(s) and volume(s)
| d) Aggregated information - Aggregated volume - Aggregated price - Aggregated total N/A - single transaction | e) Date of the transaction 26th June 2026 | f) Place of the transaction London Stock Exchange (XLON) |
1. Details of PDMR / person closely associated with them ("PCA") | a) Name Alison Littley | 2. Reason for the notification | a) Position / status Non-executive Director | b) Initial notification / amendment Initial Notification | 3. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | a) Name Eurocell plc | b) Legal Entity Identifier 213800RH62IQ7S9OFQ55 | 4. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | a) Description of the financial instrument Ordinary shares of £0.001 each in the Company ("Ordinary Shares") ISIN Number GB00BVV2KN49 | b) Nature of the transaction Purchase of Ordinary shares pursuant to the Non-executive Directors' Share Purchase Plan | c) Price(s) and volume(s)
| d) Aggregated information - Aggregated volume - Aggregated price - Aggregated total N/A - single transaction | e) Date of the transaction 26th June 2026 | f) Place of the transaction London Stock Exchange (XLON) |
1. Details of PDMR / person closely associated with them ("PCA") | a) Name Iraj Amiri | 2. Reason for the notification | a) Position / status Non-executive Director | b) Initial notification / amendment Initial Notification | 3. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | a) Name Eurocell plc | b) Legal Entity Identifier 213800RH62IQ7S9OFQ55 | 4. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | a) Description of the financial instrument Ordinary shares of £0.001 each in the Company ("Ordinary Shares") ISIN Number GB00BVV2KN49 | b) Nature of the transaction Purchase of Ordinary shares pursuant to the Non-executive Directors' Share Purchase Plan | c) Price(s) and volume(s)
| d) Aggregated information - Aggregated volume - Aggregated price - Aggregated total N/A - single transaction | e) Date of the transaction 26th June 2026 | f) Place of the transaction London Stock Exchange (XLON) |
1. Details of PDMR / person closely associated with them ("PCA") | a) Name Angela Rushforth | 2. Reason for the notification | a) Position / status Non-executive Director | b) Initial notification / amendment Initial Notification | 3. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | a) Name Eurocell plc | b) Legal Entity Identifier 213800RH62IQ7S9OFQ55 | 4. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | a) Description of the financial instrument Ordinary shares of £0.001 each in the Company ("Ordinary Shares") ISIN Number GB00BVV2KN49 | b) Nature of the transaction Purchase of Ordinary shares pursuant to the Non-executive Directors' Share Purchase Plan | c) Price(s) and volume(s)
| d) Aggregated information - Aggregated volume - Aggregated price - Aggregated total N/A - single transaction | e) Date of the transaction 26th June 2026 | f) Place of the transaction London Stock Exchange (XLON) |
Enquiries:
Eurocell plc
Vicky Williams
General Counsel & Company Secretary
Tel: 01773 842100
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy. END DSHPPUQGQUPQGAB